YIAD-0205 is an orally available Abeta(1 42) aggregation inhibitor. YIAD-0205 demonstrated in vivo efficacy in an AD transgenic mouse model with five familial AD mutations (5XFAD)[1].
Molecular Weight:
565.69
CAS Number:
[2446054-34-6]
Formula:
C26H16Br2ClN3
Target:
Amyloid-beta
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted